Takeda Pharmaceutical Company Limited (TAK) 13D/13G Filings for BiomX Inc. (PHGE)

Takeda Pharmaceutical Company Limited 13D and 13G filings for BiomX Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-08-04
7:59 pm
Unchanged
2022-03-2513GBIOMX INC
PHGE
TAKEDA PHARMACEUTICAL CO LTD
TAK
7,780
4.960%
0
(Unchanged)
Filing
2021-10-18
06:03 am
Sale
2021-10-1413GBIOMX INC
PHGE
TAKEDA PHARMACEUTICAL CO LTD
TAK
7,780
5.200%
-5,225decrease
(-40.18%)
Filing